Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of Avapritinib in Patients With CKIT or PDGFRA Mutation-Positive Malignant Solid Tumors

NCT04771520 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT04771520
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04771520 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of Avapritinib in Patients With CKIT or PDGFRA Mutation-Positive Malignant Solid Tumors
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 2
Overall status
Recruiting
Start date
January 20, 2021
Completion date
December 31, 2026
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anatomic stage iv breast cancer ajcc v8, clinical stage iv gastroesophageal junction adenocarcinoma ajcc v8, clinical stage iva gastroesophageal junction adenocarcinoma ajcc v8, clinical stage ivb gastroesophageal junction adenocarcinoma ajcc v8, locally advanced malignant solid neoplasm, locally advanced melanoma, locally advanced primary malignant central nervous system neoplasm, locally advanced sarcoma, metastatic malignant solid neoplasm, metastatic melanoma, metastatic primary malignant central nervous system neoplasm, metastatic sarcoma, pathologic stage iv gastroesophageal junction adenocarcinoma ajcc v8, pathologic stage iva gastroesophageal junction adenocarcinoma ajcc v8, pathologic stage ivb gastroesophageal junction adenocarcinoma ajcc v8, postneoadjuvant therapy stage iv gastroesophageal junction adenocarcinoma ajcc v8, postneoadjuvant therapy stage iva gastroesophageal junction adenocarcinoma ajcc v8, postneoadjuvant therapy stage ivb gastroesophageal junction adenocarcinoma ajcc v8, prognostic stage iiic breast cancer ajcc v8, prognostic stage iv breast cancer ajcc v8, stage iiic colorectal cancer ajcc v8, stage iiic lung cancer ajcc v8, stage iv colorectal cancer ajcc v8, stage iv lung cancer ajcc v8, stage iva colorectal cancer ajcc v8, stage iva lung cancer ajcc v8, stage ivb colorectal cancer ajcc v8, stage ivb lung cancer ajcc v8, stage ivc colorectal cancer ajcc v8